Portulaca oleracea-derived ELNs target the inflammatory sites in mice with colitis, inhibit the expression of pro-inflammatory cytokines, and increase the level of the anti-inflammatory cytokine IL-10, thereby alleviating colitis [22]. The gene discussed is IL10; the disease is colitis.